Tang Heng, executive vice president of NIP Group Inc., filed a Schedule 13D on November 6, 2026, disclosing beneficial ownership of 53,337,563 ordinary shares following the vesting of restricted shares on October 30, 2026.
Starwood Property Trust, Inc. (NYSE:STWD) released its third-quarter 2026 earnings press release on November 6, 2026, reporting results for the fiscal quarter ended September 30, 2026.
Applied Optoelectronics, Inc. filed an 8-K on November 6, 2026, disclosing that its Compensation Committee granted inducement equity awards covering 1,346 shares of common stock to three new employees, with a grant date of November 2, 2026.
Bausch Health Companies Inc. and its Salix Pharmaceuticals unit disclosed the presentation of a real-world research poster at The Liver Meeting 2026 in Denver, Colorado, on November 6, 2026, covering mortality and rehospitalization outcomes in patients hospitalized with severe alcohol-associated hepatitis.
Brookdale Senior Living Inc. (NYSE:BKD) released its third-quarter 2026 earnings results on November 6, 2026, reporting a narrowed net loss and double-digit Adjusted EBITDA growth alongside updated full-year 2026 guidance.
Elanco Animal Health Incorporated filed its third quarter 2026 financial results on November 6, 2026, reporting revenue of $1.265 billion and raising its full year 2026 guidance across all key metrics.
Elanco Animal Health Incorporated (NYSE:ELAN) released findings from an October 2026 U.S. consumer survey of 2,018 adults on November 6, 2026, showing sustained or increased pet health spending among the vast majority of pet owners surveyed.
Cannae Holdings, Inc. filed a current report on Form 8-K on November 5, 2026, disclosing that two directors informed the board of their intention not to stand for re-election at the company's December 11, 2026 Annual Meeting of Shareholders, and that the board approved …
Pharming Group N.V. filed a Form 6-K on November 6, 2026, announcing that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) approved an extension of the marketing authorization for Joenja (leniolisib) to include children aged 4 to 11 years weighing at least 27 …
VisionSys AI Inc filed a Form 6-K with the SEC on November 6, 2026, reporting the closing of a private placement in which the company issued 125,000,000,000 Class A ordinary shares at US$0.001 per share for an aggregate purchase price of US$125,000,000.